oral glp 1 weight loss GLP-1 Pill Delivers Injection-Like Results in Clinical Trials Evolv Launches With First-Ever Oral
Description
The results, despite optimistic interpretation by the sponsors, showed little if any cardiovascular benefit that could not have been a consequence of glucose lowering with some suggestion that the net effects of some agents might be harmful on vascular disease (6)
While incretins are effective for weight management, they often cause nausea, vomiting and other gastrointestinal issues, as well as other tolerability and safety concerns
We do not yet have evidence that they're safe for people without obesity, diabetes, and/or cardiometabolic disease
pmid:37561576 41
